NEW HAVEN, Conn., Nov. 19, 2026 (GLOBE NEWSWIRE) -- IRulya Therapeutics Inc. (Nasdaq: IRLA), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious, underserved diseases, today announced that senior management will participate in a fireside chat at the 9th Annual Evercore Healthcare Conference on November 30, 2026 at 12:55 PM EST.








